August 7, 2018
(Aeon) – The predominance of the market in US healthcare has taken plenty of flak for promoting profit over quality, and for crescendoing costs. But there’s a deeper set of issues surrounding how the market influences – or distorts, maybe – the very bedrock of healthcare and medicine. In a system driven primarily by profit, certain diseases or treatments must languish simply because they’re not lucrative. And how can such a system do other than favour revenue over patients?